XML 40 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2020
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

    

Three Months Ended September 30, 

    

2019

    

2020

Cost of goods sold

$

171

$

179

Selling, general and administrative

 

6,085

 

5,785

Research and development

 

160

 

145

Stock-based compensation expense

$

6,416

$

6,109

Summary of stock option activity

Weighted

Average

Weighted-Average

Aggregate

Number of

Exercise

Remaining Contractual

Intrinsic Value

    

Options

    

Price

    

Term

    

(in thousands)

Outstanding at June 30, 2020

 

326,304

 

$

44.41

 

Granted

 

526

75.96

Exercised

 

(69,195)

27.42

Expired or forfeited

 

(1,009)

85.87

Outstanding at September 30, 2020

 

256,626

48.89

2.8 years

$

7,814

Exercisable at September 30, 2020

228,022

43.97

 

2.0 years

7,756

Summary of RSU award activity

Weighted-

Average

    

Shares

    

Fair Value

Nonvested at June 30, 2020

 

423,590

$

88.68

Granted

 

303,071

80.13

Vested

 

(286,701)

86.38

Forfeited

 

(2,270)

86.09

Nonvested at September 30, 2020

 

437,690

$

84.28